Biologics are more effective at treating adult-onset Still’s disease (AOSD) than are glucocorticoids or conventional disease-modifying antirheumatic drugs (DMARDs), according to a new retrospective ...

Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...

Initiating biologic therapy as a first-line systemic treatment for moderate-to-severe plaque psoriasis was associated with better skin clearance, low risks for chronic comorbidities, and improved ...

Antibiotic exposure in psoriasis patients is linked to increased biologic therapy discontinuation, with risk rising with multiple courses, suggesting gut microbiota alterations may play a role. The ...

There are a number of misconceptions about the use of biologic medications for atopic dermatitis. Find out what experts say ...

SkinTE®would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 years, if approved.SkinTE® is a first-in-class autologous ...

Please provide your email address to receive an email when new articles are posted on . Shorter surgery-free survival was observed among patients on conventional therapy only in the pre-biologics era.

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...

Please provide your email address to receive an email when new articles are posted on . Biologic therapies are underutilized in non-white populations. By identifying barriers to specific biologic ...

Although biologics can be effective in reducing allergy symptoms, the high cost of these medications must be weighed when determining whether to use them for allergic rhinitis. But these typical ...

Biotech startup Zumutor Biologics has raised $7.3 Mn (about ₹70 Cr) in its Series B funding round from existing investors Accel and Bharat Innovation Fund, alongside new investors Premji Invest, and ...